Rate My Professor Jane Holmes-Walker

Dr Holmes-Walker's academic interests and research specializations encompass type 1 diabetes management, clinical islet cell transplantation programs, insulin pump therapy including continuous subcutaneous insulin infusion, models of care for young adults transitioning from pediatric to adult diabetes services, and the impact of digital technologies such as continuous glucose monitoring and hybrid closed-loop automated insulin delivery systems on glycemic outcomes, hypoglycemia, and quality of life. She has authored 56 publications, achieving 1,556 citations. Prominent publications include "Benchmarking care outcomes for young adults with type 1 diabetes across Australia" (2021, Endocrinology, Diabetes & Metabolism); "Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During Journeys" (2022, Diabetes Technology & Therapeutics); "Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis" (2022, Value in Health); "Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Long-term HbA1c in 7,961 Children and Young Adults in the Australasian Diabetes Data Network" (2022, Diabetes Care); "The Diabetes Management Experiences Questionnaire: Psychometric validation among adults with type 1 diabetes" (2023); and "Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes" (2024, Internal Medicine Journal). She has published widely on diabetes and osteoporosis topics.